DR. JEROME MARVIN FELSENSTEIN, M.D.
Dermatology at Highland Ave, Crotonville, NY

License number
New York 112406
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
100 S Highland Ave, Crotonville, NY 10562
Phone
(914) 941-5770
(914) 941-3141 (Fax)

Professional information

Jerome M Felsenstein Photo 1

Dr. Jerome M Felsenstein, Ossining NY - MD (Doctor of Medicine)

Specialties:
Dermatology
Address:
Advanced Dermatology
100 S Highland Ave, Ossining 10562
(914) 941-5770 (Phone)
Certifications:
Dermatology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Advanced Dermatology
100 S Highland Ave, Ossining 10562
NYU Langone Medical Center
550 1St Ave, New York 10016
Phelps Memorial Hospital Association
701 North Broadway, Sleepy Hollow 10591
Education:
Medical School
New York University
Graduated: 1971
Bellevue/Manhattan Va/Nyu
Kings Co-Suny Downstate


Jerome Marvin Felsenstein Photo 2

Jerome Marvin Felsenstein, Ossining NY

Specialties:
Dermatologist
Address:
100 S Highland Ave, Ossining, NY 10562
701 N Broadway, Sleepy Hollow, NY 10591
Education:
New York University, School of Medicine - Doctor of Medicine
Kings County Hospital Center - Residency - Dermatology
Board certifications:
American Board of Dermatology Certification in Dermatology


Jerome Felsenstein Photo 3

Laser Dermablator And Dermablation

US Patent:
6447503, Sep 10, 2002
Filed:
Nov 1, 2000
Appl. No.:
09/606351
Inventors:
James Jeffrey Wynne - Mount Kisco NY
Stephen Henry Gomory - Tarrytown NY
Jerome Marvin Felsenstein - Ossining NY
Assignee:
International Business Machines Corporation - Armonk NY
International Classification:
A61B 1818
US Classification:
606 9, 606 10, 606 12
Abstract:
A laser system (called a UV Dermablator) and method that enables a clean, precise removal of skin while minimizing collateral damage to the skin underlying the treated region. The depth of ablation can be controlled via feedback from the physiology of the skin, namely the infusion of blood into the area of excision when skin has been ablated to a sufficient depth to produce bleeding. A second laser, such as a uv light source with a different wavelength, to penetrate the blood, heating it sufficiently to coagulate the blood. Other features provide precise control, permitting the epidermis to be removed down to the papillary dermis, following the undulations of the papillary dermis. This lateral and depth control may be accomplished by using careful observation, assisted by spectroscopic detection, to identify when the epidermis has been removed, exposing the underlying dermis, with spatial resolution appropriate for the spacing of the undulations of the papillary dermis. Yet other features which provide a feedback control mechanism which utilizes the optical characteristics such as the color, appearance and remittance of the definable skin layers to control the depth of ablation at each location.


Jerome Felsenstein Photo 4

System And Method For Modification And/Or Smoothing Of Tissue With Laser Ablation

US Patent:
2013019, Jul 25, 2013
Filed:
Apr 12, 2011
Appl. No.:
13/640588
Inventors:
Daniel Patrick Connors - Pleasant Valley NY, US
Jerome Felsenstein - Ossining NY, US
Robert E. Trzcinski - Rhinebeck NY, US
James J. Wynne - Mt. Kisco NY, US
Assignee:
INTERNATIONAL BUSINESS MACHINES CORPORATION - ARMONK NY
International Classification:
A61B 18/20
US Classification:
606 17
Abstract:
Disclosed is an improved system and method for efficiently removing tissue using laser ablation. A first laser emits a first laser beam with a variable first integrated fluence sufficient to ablate tissue. The first laser beam is movably positioned over one or more surfaces of the tissue and the first integrated fluence varies over different levels with position, so different thicknesses of tissue are ablated at different surface positions in order to modify the contour of the surface of the tissue. Modifications include tissue smoothing, removing, feathering, sharpening, and roughening. In one preferred embodiment the tissue is eschar that is removed, unveiling viable tissue. In alternate preferred embodiments, one or more additional lasers beams with different wavelengths, with integrated fluence sufficient to ablate tissue, are moved over the surface of the tissue until a second ablation reaches a second self-termination point, e.g., determined by affects of chemicals below the termination point that absorb the second laser beam without producing the temperature increase necessary for ablation to continue.